Monoamine oxidase inhibitors reduce conditioned fear stress-induced freezing behavior in rats

European Journal of Pharmacology

Volumn 406, Issue 3, 2000, Pages 411-418

  Maki, Yuji ^a   Inoue, Takeshi ^a   Izumi, Takeshi ^a   Muraki, Ihoko ^a   Ito, Koichi ^a   Kitaichi, Yuji ^a   Li, Xiaobai ^a   Koyama, Tsukasa ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Anxiety; Conditioned fear stress; Freezing behavior; Monoamine oxidase inhibitor

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; CLORGYLINE; LAZABEMIDE; MONOAMINE OXIDASE INHIBITOR; N (2 AMINOETHYL) 5 (3 FLUOROPHENYL) 4 THIAZOLECARBOXAMIDE; PHENELZINE; SELEGILINE; TANDOSPIRONE; TRANYLCYPROMINE;

ACCLIMATIZATION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONDITIONING; DRUG EFFECT; ELECTRIC SHOCK; ENZYME INHIBITION; FEAR; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC NERVE CELL; SOCIAL PHOBIA; STRESS; TRANQUILIZING ACTIVITY;

ANIMAL; ANTI-ANXIETY AGENTS; BEHAVIOR, ANIMAL; DRUG THERAPY, COMBINATION; FEAR; MALE; MICRODIALYSIS; MONOAMINE OXIDASE INHIBITORS; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; SUPPORT, NON-U.S. GOV'T;

EID: 0034693070     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00706-8     Document Type: Article

References (34)

1. In vivo evidence for the reversible action of the monoamine oxidase inhibitor brofaromine on 5-hydroxytryptamine release in rat brain
2. Effects of selective monoamine oxidase inhibitors on the in vivo release and metabolism of dopamine in the rat striatum
3. Monoamine oxidase inhibitors increase preferentially extracellular 5-hydroxytryptamine in the midbrain raphe nuclei. A brain microdialysis study in the awake rat
4. Animal models of anxiety: The effects of compounds that modify 5-HT neurotransmission
5. Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A
6. From moclobemide to Ro 19-6327 and Ro 41-1049: The development of a new class of reversible, selective MAO-A and MAO-B inhibitors
7. Pharmacokinetics and pharmacodynamics of single and multiple doses of the MAO-B inhibitor lazabemide in healthy subjects
8. Serotonin in psychiatric pathophysiology: A review of data from experimental and clinical research. Progress in Basic Clinical Pharmacology
9. Conditional and unconditional components of post-shock freezing
10. Conditional analgesia, defensive freezing, and benzodiazepines
11. Chronic inhibition of monoamine oxidase type A increases noradrenaline release in rat frontal cortex
12. Effects of acute and chronic anti-panic drug administration on conflict behavior in the rat
13. A randomized clinical trial of phenelzine and imipramine for posttraumatic stress disorder
14. Analysis of tandospirone (SM-3997) interactions with neurotransmitter receptor binding sites
15. Serotonin reuptake inhibitors reduce conditioned fear stress-induced freezing behavior in rats
16. The effects of the co-administration of 5-HT1(A) receptor antagonists with an SSRI in conditioned fear stress-induced freezing behavior
17. Effects of conditioned fear stress on serotonin neurotransmission and freezing behavior in rats
18. The role of central dopaminergic and serotonergic systems of rats in conditioned fear stress, an animal model of anxiety
19. Serotonergic activation reduces defensive freezing in the conditioned fear paradigm
20. Effect of citalopram, a selective serotonin reuptake inhibitor, on the acquisition of conditioned freezing
21. Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine
22. Phenelzine vs. atenolol in social phobia. A placebo-controlled comparison
23. Effect of subchronic lithium carbonate treatment on anxiolytic-like effect of citalopram and MKC-242 in conditioned fear stress in the rat
24. Competitive and noncompetitive NMDA antagonists block sensitization to methamphetamine
25. Deprenyl is metabolized to methamphetamine and amphetamine in man
26. Comparison of neuroendocrine and behavioral effects of ipsapirone, a 5-HT(1A) agonist, in three stress paradigm: Immobilization, forced swim and conditioned fear
27. Placebo-controlled trial of moclobemide in social phobia
28. Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms
29. MAO inhibitors in panic disorder: Clinical effects of treatment with brofaromine. A double blind placebo controlled study
30. Pharmacotherapy of social phobia. A controlled study with moclobemide and phenelzine
31. Deprenyl: Loss of selectivity for inhibition of B-type MAO after repeated treatment
32. The reversible MAO inhibitor, brofaromine, inhibits serotonin uptake in vivo
33. New directions in monoamine oxidase A and B: Selective inhibitors and substrates